HIV research in South Africa: Advancing life

S Afr Med J. 2019 Dec 5;109(11b):36-40. doi: 10.7196/SAMJ.2019.v109i11b.14264.

Abstract

South African (SA) researchers have made both national and global contributions to HIV prevention and treatment. Research conducted in SA has contributed markedly to improved survival in HIV-infected infants, children and adults. The translation of clinical research into practice has enabled the curtailment of paediatric HIV in SA. Along with international collaborators, SA has made pivotal contributions to biomedical prevention modalities including medical male circumcision and oral and topical microbicides, and is undertaking pivotal HIV vaccine research. Research into the structural and psychosocial drivers of HIV infection will be critical for sustaining biomedical interventions, and necessary to end AIDS.

MeSH terms

  • AIDS Vaccines / therapeutic use*
  • Administration, Intravaginal
  • Anti-HIV Agents / therapeutic use*
  • Biomedical Research
  • Circumcision, Male*
  • Condoms
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • Humans
  • Male
  • Pre-Exposure Prophylaxis*
  • South Africa
  • Survival Rate

Substances

  • AIDS Vaccines
  • Anti-HIV Agents